Drug profile · INN
vimseltinib
ROMVIMZA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
vimseltinib (ROMVIMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN vimseltinib
Brand ROMVIMZA
Route ORAL
Formulation CAPSULE
ATC code L01EX
Frequently asked questions
What is vimseltinib?
vimseltinib (ROMVIMZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vimseltinib?
ROMVIMZA is a marketed brand name for vimseltinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vimseltinib?
vimseltinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.